Switch to:
Medtronic PLC (NYSE:MDT)
Research and Development
$2,224 Mil (TTM As of Apr. 2016)

This is the expense the company spent on research and development. Medtronic PLC's research and development for the three months ended in Apr. 2016 was $575 Mil. Its research and development for the trailing twelve months (TTM) ended in Apr. 2016 was $2,224 Mil.


Definition

This is the expense the company spent on research and development.

Medtronic PLC Research & Development for the trailing twelve months (TTM) ended in Apr. 2016 was 558 (Jul. 2015 ) + 545 (Oct. 2015 ) + 546 (Jan. 2016 ) + 575 (Apr. 2016 ) = $2,224 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms

Gross Profit


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Medtronic PLC Annual Data

Apr07Apr08Apr09Apr10Apr11Apr12Apr13Apr14Apr15Apr16
Research & Development 1,2391,2751,3551,4601,5081,4901,5571,4771,6402,224

Medtronic PLC Quarterly Data

Jan14Apr14Jul14Oct14Jan15Apr15Jul15Oct15Jan16Apr16
Research & Development 360385365374373528558545546575
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK